Pharmacopsychiatry 2005; 38 - 91
DOI: 10.1055/s-2005-862704

The international Society for Pharmacoepidemiology

JW Van der Velden 1
  • 1PharmaNet AG, Zumikon, Switzerland

The International Society for Pharmacoepidemiology (ISPE) is an international forum for the open exchange of scientific information among academia, government, and industry and for the development of policy; a provider of education; and an advocate for the fields of pharmacoepidemiology and therapeutic risk management.

The International Society for Pharmacoepidemiology (ISPE) is a non-profit international professional membership organization dedicated to promoting pharmacoepidemiology, the science which applies epidemiologic approaches to studying the use, effectiveness, value and safety of pharmaceuticals. ISPE is firmly committed to providing an unbiased scientific forum to the views of all parties with interests in drug development, drug delivery, drug use, drug costs, and drug effects.

ISPE members represent the various scientific disciplines involved in studying drugs. Members are employed by the pharmaceutical industry, academic institutions, government agencies, non-profit and for-profit private organizations. Members have degrees in a number of fields, including epidemiology, biostatistics, medicine, nursing, pharmacology, pharmacy, law, health economics, and journalism. With members in 53 countries and national chapters in Argentina, Belgium, Denmark, and the Netherlands, ISPE truly provides an international forum for sharing knowledge and scientific approaches to foster the science of pharmacoepidemiology.

ISPE sponsors conferences and seminars, a quarterly newsletter, and an official journal – Pharmacoepidemiology and Drug Safety, published by Wiley.